HQY

Insider Buying week 12-17-21

by

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. Microsoft dipped 0.3% Friday, bringing its weekly decline to nearly 5.5%. Alphabet and Apple fell more than 4%. A handful of tech stocks have been propelling the major averages all year and it’s only natural to see some profit-taking.  I tried to borrow some ARKK stock but there was none available to short. Betting against Infinite multiples has been the most reliable trade of the last month. There was somewhat of a short squeeze on … Read more

Eyenovia merits a closer look $EVEN

by

CEO Ianchulev purchase of microcap Eyenovia merits a closer look. This was part of a spot 4.38 M share spot secondary at $2.78. Eyenovia is marketing a high tech eyedropper.  The 100-year-old eyedropper could be disrupted by Eyenovia. Buyer beware though, it’s easy to get in but not so easy to get out of this low volume late-stage money-losing biotech. Health Equity insiders score big by scooping up 10,000 shares each on secondary. Unfortunately, there was no way to act on this until the 15th SEC filing after the stock had risen 10 points. Insiders are required to file within … Read more